What is the purpose of the Merck/Schering-Plough Pharmaceuticals joint venture?

Merck & Co., Inc., and Schering-Plough Corporation formed this joint venture to develop and market new prescription medicines for cholesterol management.

Where is Merck/Schering-Plough Pharmaceuticals headquartered?

Our headquarters are located at:
351 N. Sumneytown Pike
PO Box 1000
North Wales, PA 19454

What products does Merck/Schering-Plough offer?

Currently, Merck/Schering-Plough offers 2 medicines: VYTORIN^® (ezetimibe/simvastatin) and ZETIA^® (ezetimibe). To learn more about these products, visit vytorin.com and zetia.com.

How do I know if the medicines developed by Merck/Schering-Plough are right for me?

Talk to your doctor to determine whether VYTORIN or ZETIA are right for you.

Who can answer my questions about Merck/Schering-Plough Pharmaceuticals?

For questions regarding press and media, contact Skip Irvine at 267-305-5397. For questions regarding VYTORIN, call 1-877-VYTORIN; for questions regarding ZETIA, call 1-800-98-ZETIA. For all other questions, call 1-866-637-2501.

Where can I find corporate information about Merck/Schering-Plough Pharmaceuticals?

Corporate information about Merck & Co., Inc., and Schering-Plough Corporation, including annual reports for these companies, is available online at merck.com and schering-plough.com.